MannKind Corp
MNKD
#5772
Rank
NZ$2.26 B
Marketcap
NZ$7.32
Share price
5.34%
Change (1 day)
18.75%
Change (1 year)

MannKind Corp (MNKD) - Total assets

Total assets on the balance sheet as of March 2026 : NZ$1.31 Billion

According to MannKind Corp's latest financial reports the company's total assets are NZ$1.31 Billion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

MannKind Corp - Total assets on balance sheet (from 2004 to 2026)

Total assets by year

Year Total assets Change
2024-12-31NZ$0.69 B-7.06%
2023-12-31NZ$0.75 B61.57%
2022-12-31NZ$0.46 B-1.09%
2021-12-31NZ$0.47 B212.37%
2020-12-31NZ$0.15 B8.16%
2019-12-31NZ$0.13 B-13.33%
2018-12-31NZ$0.16 B34.83%
2017-12-31NZ$0.11 B-22.95%
2016-12-31NZ$0.15 B-16.32%
2015-12-31NZ$0.18 B-63.31%
2014-12-31NZ$0.50 B59.95%
2013-12-31NZ$0.31 B3.03%
2012-12-31NZ$0.30 B19.48%
2011-12-31NZ$0.25 B-28.85%
2010-12-31NZ$0.35 B5.51%
2009-12-31NZ$0.34 B-30.02%
2008-12-31NZ$0.48 B-31.39%
2007-12-31NZ$0.70 B-7.4%
2006-12-31NZ$0.76 B129.3%
2005-12-31NZ$0.33 B45.83%
2004-12-31NZ$0.22 B18.32%
2003-12-31NZ$0.19 B-3.27%
2002-12-31NZ$0.20 B

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
Pfizer
PFE
NZ$367.29 B 27,790.54%๐Ÿ‡บ๐Ÿ‡ธ USA
Novo Nordisk
NVO
NZ$153.24 B 11,536.41%๐Ÿ‡ฉ๐Ÿ‡ฐ Denmark
Eli Lilly
LLY
NZ$206.23 B 15,560.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$227.65 B 17,187.01%๐Ÿ‡บ๐Ÿ‡ธ USA
Halozyme Therapeutics
HALO
NZ$4.72 B 259.04%๐Ÿ‡บ๐Ÿ‡ธ USA
Nektar Therapeutics
NKTR
NZ$1.35 B 2.53%๐Ÿ‡บ๐Ÿ‡ธ USA